- Home
- RRC vs CORT Comparison
RRC vs CORT Comparison
Compare RRC & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRC
- CORT
- Stock Information
- Founded
- RRC 1976
- CORT 1998
- Country
- RRC United States
- CORT United States
- Employees
- RRC N/A
- CORT N/A
- Industry
- RRC Oil & Gas Production
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- RRC Energy
- CORT Health Care
- Exchange
- RRC Nasdaq
- CORT Nasdaq
- Market Cap
- RRC 8.0B
- CORT 7.1B
- IPO Year
- RRC N/A
- CORT N/A
- Fundamental
- Price
- RRC $37.86
- CORT $70.23
- Analyst Decision
- RRC Hold
- CORT Strong Buy
- Analyst Count
- RRC 18
- CORT 4
- Target Price
- RRC $42.00
- CORT $142.00
- AVG Volume (30 Days)
- RRC 2.9M
- CORT 1.4M
- Earning Date
- RRC 04-22-2025
- CORT 05-05-2025
- Dividend Yield
- RRC 0.95%
- CORT N/A
- EPS Growth
- RRC N/A
- CORT 8.36
- EPS
- RRC 1.11
- CORT 1.14
- Revenue
- RRC $2,610,836,000.00
- CORT $685,446,000.00
- Revenue This Year
- RRC $34.77
- CORT $36.81
- Revenue Next Year
- RRC $8.93
- CORT $32.00
- P/E Ratio
- RRC $32.97
- CORT $61.85
- Revenue Growth
- RRC 12.00
- CORT 30.93
- 52 Week Low
- RRC $27.29
- CORT $25.35
- 52 Week High
- RRC $41.95
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- RRC 62.18
- CORT 50.58
- Support Level
- RRC $33.42
- CORT $68.92
- Resistance Level
- RRC $35.31
- CORT $75.41
- Average True Range (ATR)
- RRC 1.06
- CORT 3.76
- MACD
- RRC 0.51
- CORT -0.19
- Stochastic Oscillator
- RRC 99.01
- CORT 57.96
About RRC Range Resources Corporation
Fort Worth-based Range Resources is an independent exploration and production company with that focuses entirely on its operations in the Marcellus Shale in Pennsylvania. At year-end 2024, Range Resources' proven reserves totaled 18.1 trillion cubic feet equivalent, with net production of 2.18 billion cubic feet equivalent per day. Natural gas accounted for 68% of production.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.